Authors : Induru Jagadeesh; Mashetti Vishnu Vardhan

Volume/Issue : Volume 11 - 2026, Issue 6 - June

Google Scholar : https://tinyurl.com/zhev9t9x

Scribd : https://tinyurl.com/2d6rj5hf

DOI : https://doi.org/10.38124/ijisrt/26jun184

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Abstract : Aim: This review aims to present a clear and comprehensive understanding of topical spray drug delivery systems, with emphasis on their formulation approaches, evaluation methods, mechanism of skin delivery, and their growing role in dermatological therapy.  Objectives: The main objective is to explore how topical sprays have evolved from conventional aerosol-based products to more advanced systems such as pump sprays, film-forming formulations, and nano-carrier assisted delivery systems. It also focuses on highlighting their advantages over traditional semisolid dosage forms like creams and ointments, along with discussing key formulation ingredients, skin penetration enhancement strategies, evaluation techniques, and clinical applications in various skin conditions.  Results: Literature analysis shows that topical sprays provide several practical and therapeutic benefits, including easy and hygienic application, uniform spreading over the skin, rapid drying, and improved patient comfort and compliance. Advanced systems such as film-forming sprays and nano-based formulations further improve drug delivery by enhancing penetration through the stratum corneum, increasing skin retention, and enabling controlled and sustained release. Evaluation studies indicate that parameters such as droplet size, spray pattern, drying time, dose uniformity, and skin permeation play a crucial role in determining the overall performance and effectiveness of these formulations.  Conclusion: Topical spray systems have emerged as a promising and efficient approach in modern dermatological drug delivery. Ongoing innovations in formulation design and delivery technology are expected to further enhance their therapeutic performance, safety, and acceptance in both pharmaceutical and cosmetic applications.

Keywords : Topical Sprays, Dermatological Drug Delivery, Film-Forming Systems, Nanocarriers, Skin Permeation, Patient Compliance.

References :

1. Raval A. Formulation and Evaluation of Itraconazole Topical Spray. Research Journal of Topical and Cosmetic Sciences. 2015 Jul 1;6(2):91. DOI: 10.5958/2321-5844.2015.00013.8
2. Banker GS, Rhodes CT. Modern Pharmaceutics. 2nd ed. Vol. 40. New York: Marcel Dekker; 1979. p. 263-273, 283, 286-287, 299-311.
3. Lemberger AP. A Handbook of Non-Prescription Drugs. Washington (DC): American Pharmaceutical Association; 1973. p. 161.
4. Wilkes GL, Brown IA, Wilnauer RH. CRC critical reviews in bioengineering. CRC Crit Rev Bioeng. 1973 Aug;1:453.
5. Umar AK, Butarbutar M, Sriwidodo S, Wathoni N. Film-Forming Sprays for Topical Drug Delivery. Drug Des Devel Ther. 2020 Jul 22;14:2909-2925. doi: 10.2147/DDDT.S256666 PMID: 32884234; PMCID: PMC7434377.
6. Kumar D, Nirmale P, Kondaveeti SB, Agrawal M, Singh TG, Awasthi A, Kumar M. Therapeutic potential of spray-based delivery system for the treatment of dermatological disorders: clinical insights and formulation advances. International Journal of Pharmaceutics. 2026 Mar 12:126766.https://doi.org/10.1016/j.ijpharm.2026.126766
7. Trivedi, H., Bhatt, I., Dolia, K., Rana, M., Bhatt, S. and Koradia, S., 2026. From Mist to Medicine: Wound healing Revolution with Liquid Sprays. International Journal of Research in Pharmacy and Allied Science, 5(2), pp.113-150.  https://doi.org/10.71431/IJRPAS.2026.5210
8. Autade, V.V. and Shelke, S.J. (2024). A Comprehensive Review on Topical Gel. International Journal of Pharmaceutical Research and Applications, 9(2), pp. 693–699. DOI: 10.35629/7781-0902693699
9. Bakhrushina EO, Ivkin DV, et al. Spray Film-Forming Systems as Promising Topical In Situ Systems: A Review. Pharmaceutics. 2022;14(1):123. DOI: 10.3390/pharmaceutics14010123
10. Shakeel F, et al. Nanoemulsion as topical drug carriers: preparation and characterization. Drug Dev Ind Pharm. 2007;33(12):1393–1400. DOI: 10.1080/03639040701635514
11. Mithal B.M., and Saha R.N., “A Hand Book of Cosmetics”, Ist edition, Vallabh Prakashan Delhi, 2003, 11-17,21-22,37-38,61-89,90-93,177,214-215.
12. Barry, B.W., 1983. Dermatological Formulations: Percutaneous Absorption. New York: Marcel Dekker Inc.
13. Williams AC, Barry BW. Penetration enhancers. Adv Drug Deliv Rev. 2012;64:128–137. DOI: 10.1016/j.addr.2012.09.032.
14. Vyas S. and Khar R.K., “Controlled Drug Delivery- Concept and Advances”, Vallabh Prakashan, 2002.
15. Kaur I.P., Smith L.I., “Percutaneous Absorption-Penetration Enhancers”, 1998, 34-33.
16. Shah     V.P.,     Williams     R.L.,“Skin     Penetration     Enhancement     Clinical Pharmacological and Regulatory Considerations”, 1993, 27-35.
17. Osborne D.W., Henke J.J., “Skin Penetration Enhancers Cited in the Technical Literature”, Pharm. tech, 1997, 21,50-66.
18. Stillwell  G.K.,“Electrical  Stimulation  and  Iontophoresis  in  Krussen  F.H.”, Saunders Company, 1971, 14.
19. Sloan J.B. and Soltani K., “Journal of American Academic Dermatology.”, 1986, 30-72.
20. Prausnitz  M.R.  and  Bose  V.G., “Electroporation:  In  Percutaneous Penetration Enhancers”, CRC Press, Bocaraton. 1995, 393-405
21. Shyamala B., Kumari L.P. and Harish C.G., “Indian Journal of Pharmaceutical Science”, 64(4), July-Aug 2005, 475-476.
22. Barry BW. Dermal absorption enhancement mechanisms and topical drug delivery. Adv Drug Deliv Rev. 2001;46(1–3):69–92. doi: 10.1016/S0169-409X(00)00160-3.
23. Hadgraft J, Lane ME. Skin permeation: The role of formulation factors. Int J Pharm. 2005;288(1):1–12. DOI: 10.1016/j.ijpharm.2005.07.014
24. Bos JD, Meinardi MM. The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp Dermatol. 2000;9(3):165–169. doi:10.1034/j.1600-0625.2000.009003165.x.
25. Allen LV Jr, Popovich NG, Ansel HC. Ansel’s Pharmaceutical Dosage Forms and Drug Delivery Systems. 9th ed. Lippincott Williams & Wilkins; 2011.
26. Manca ML, et al. Lipid nanoparticles as topical drug carriers: recent advances and opportunities. J Dermatol Sci. 2021;101(1):13–25.
27. Lachman L, Lieberman HA, Kanig JL. The Theory and Practice of Industrial Pharmacy. 3rd ed. Varghese Publishing House; 2009.
28. Aulton ME, Taylor K. Aulton’s Pharmaceutics: The Design and Manufacture of Medicines. 5th ed. Elsevier; 2018.
29. Lane ME. Skin penetration enhancers. Int J Pharm. 2013;447(1–2):12–21. DOI: 10.1016/j.ijpharm.2013.02.040.
30. Shetty A, Dubey A, Chrystle J et al. Fabrication and in vitro characterization of curcumin film-forming topical spray: An integrated approach for enhanced patient comfort and efficacy [version 1; peer review: 3 approved]. F1000Research 2024, 13:138 https://doi.org/10.12688/f1000research.142860.1
31. Kathpalia Harsha. Film forming systems for topical and transdermal drug delivery. Asian Journal of Pharmaceutical Sciences. 2017; doi:10.1016/J.AJPS.2017.07.004
32. Mehmood Y, Shahid H, Nazir R, Uddin MN, Nur-e-Alam M, Bourhia M, Almaary KS, Kazi M, Mahamat OB. Development of nanospray loaded with ciclopirox for dermal fungus treatment: determination of pro-inflammatory interleukin IL-2 mRNA expression. BMC Pharmacol Toxicol. 2025;26(1):32. doi:10.1186/s40360-025-00853-y. PMCID: PMC11827433.
33. Kaur IP, Kakkar S. Topical delivery of antifungal agents. Expert Opin Drug Deliv. 2010;7(11):1303–1327. doi: 10.1517/17425247.2010.525230
34. Choochuay K, Sawatdee S, Chanthorn W. The efficacy of topical spray containing Centella asiatica extract on excision wound healing in rats. Asian J Pharm Sci. 2016;11(1):132–133. doi: 10.1016/j.ajps.2015.11.091.
35. Becker DE, Reed KL. Local anesthetics: review of pharmacological considerations. Anesthesia progress. 2012 Jan 1;59(2):90-102. DOI: 10.2344/0003-3006-59.2.90.
36. Dai T, et al. Topical antimicrobials for burn wound infections. Recent Pat Anti Infect Drug Discov. 2010;5(2):124–151.DOI: 10.2174/157489110791233522.
37. Havlickova B, Czaika VA, Friedrich M. Epidemiological trends in skin mycoses worldwide. Mycoses. 2008;51 Suppl 4:2–15. doi:10.1111/j.1439-0507.2008.01606.x.

38. Wang C, Swerdloff RS, Iranmanesh A, Dobs A, Snyder PJ, Cunningham G, et al. Transdermal testosterone gel and spray therapy. Expert Opin Pharmacother. 2011;12(11):1753–1768. doi:10.1517/14656566.2011.580657.
39. Wiedersberg S, Leopold CS, Guy RH. Bioavailability and bioequivalence of topical glucocorticoids. Eur J Pharm Biopharm. 2008;68(3):453–466. doi:10.1016/j.ejpb.2007.08.007.
40. Moreno MA, Ballesteros MP. Film-forming systems in topical and transdermal drug delivery. Drug Dev Ind Pharm. 2011;37(6):647–655. doi:10.3109/03639045.2010.543960.
41. Simon JA, Goldstein I, Kim NN, Davis SR, Kellogg-Spadt S, Bachmann GA, et al. The efficacy and safety of estradiol topical spray (Evamist®) in postmenopausal women with vasomotor symptoms. Obstet Gynecol. 2006;107(6):1472–1480. doi:10.1097/01.AOG.0000218095.54096.cf.
42. Boateng JS, Matthews KH, Stevens HN, Eccleston GM. Wound healing dressings and drug delivery systems: a review. J Pharm Sci. 2008;97(8):2892–2923. doi:10.1002/jps.21210.
43. Gupta AK, Versteeg SG, Shear NH. Onychomycosis in the 21st Century: An Update on Diagnosis, Epidemiology, and Treatment. J Cutan Med Surg. 2017;21(6):525–539. doi:10.1177/1203475417716362.
44. Bigliardi PL, Alsagoff SAL, El-Kafrawi HY, Pyon JK, Wa CTC, Villa MA. Povidone iodine in wound healing: A review of current concepts and practices. Int J Surg. 2017;44:260–268. doi:10.1016/j.ijsu.2017.06.073.
45. Gupta AK, Cooper EA. Update in antifungal therapy of dermatophytosis. Mycopathologia. 2008;166:353–367. DOI: 10.1007/s11046-008-9109-0.
46. Benson HAE. Transdermal drug delivery: penetration enhancement techniques. Curr Drug Deliv. 2005;2(1):23–33. doi:10.2174/1567201052772915.
47. Choi FD, Juhasz MLW, Mesinkovska NA. Topical ketoconazole: a systematic review of current dermatological applications and future developments. J Dermatolog Treat. 2019;30(8):760–771. doi:10.1080/09546634.2019.1573309.
48. Del Rosso JQ. Management of superficial fungal infections. J Clin Aesthet Dermatol. 2013;6(1):19–27.
49. Shellow WVR. 2% Miconazole nitrate powder in aerosol spray form: its efficacy in treating tinea pedis. J Int Med Res. 1982;10(1):28–31. doi:10.1177/030006058201000105.
50. Del Rosso JQ, Kircik LH. Optimizing topical antifungal therapy for superficial cutaneous fungal infections: focus on topical naftifine for cutaneous dermatophytosis. J Drugs Dermatol. 2013;12(11 Suppl):S165-S171.
51. Mura S, Nicolas J, Couvreur P. Stimuli-responsive nanocarriers for drug delivery. Nature materials. 2013 Nov;12(11):991-1003. https://doi.org/10.1038/nmat3776
52. Montenegro L, et al. Nanotechnology-based topical formulations for skin delivery. Pharmaceutics. 2020;12(8):735. DOI: 10.3390/pharmaceutics12080735.
53. Vehring R. Pharmaceutical particle engineering via spray drying. Pharm Res. 2008;25(5):999–1022. doi: 10.1007/s11095-007-9475-1.